Medifast (MED) Share-based Compensation (2010 - 2026)

Medifast has reported Share-based Compensation for 17 years, with the latest figure at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 1.76% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $7.6 million (up 6.78% YoY), and the FY2025 full-year result was $7.6 million, up 3.75% from the prior year.
• Share-based Compensation for Q1 2026 stood at $1.9 million, down from $2.2 million in the prior quarter.
• The five-year high for Share-based Compensation was $3.0 million in Q3 2022, with the low at $606000.0 in Q1 2023.
• Historically, Share-based Compensation has averaged $2.1 million across 5 years, with a median of $2.3 million in 2022.
• The largest YoY upside for Share-based Compensation was 258.25% in 2024 against a maximum downside of 77.35% in 2024.
• Medifast's Share-based Compensation stood at $2.9 million in 2022, then dropped by 18.88% to $2.4 million in 2023, then decreased by 10.91% to $2.1 million in 2024, then grew by 1.88% to $2.2 million in 2025, then slipped by 12.71% to $1.9 million in 2026.
• The last three Share-based Compensation figures came in at $1.9 million (Q1 2026), $2.2 million (Q4 2025), and $910000.0 (Q3 2025), per Business Quant data.